BPG is committed to discovery and dissemination of knowledge
Cited by in CrossRef
Number Cited Articles
1
Dongjun Lee, Dong-Soo Suh, Sue Chin Lee, Gabor J. Tigyi, Jae Ho Kim. Role of autotaxin in cancer stem cellsCancer and Metastasis Reviews 2018; 37(2-3): 509 doi: 10.1007/s10555-018-9745-x
2
Ingun Heiene Tveteraas, Monica Aasrum, Ingvild Johnsen Brusevold, John Ødegård, Thoralf Christoffersen, Dagny Sandnes. Lysophosphatidic acid induces both EGFR-dependent and EGFR-independent effects on DNA synthesis and migration in pancreatic and colorectal carcinoma cellsTumor Biology 2016; 37(2): 2519 doi: 10.1007/s13277-015-4010-1
3
Ming Quan, Jiu-jie Cui, Xiao Feng, Qian Huang. The critical role and potential target of the autotaxin/lysophosphatidate axis in pancreatic cancerTumor Biology 2017; 39(3): 101042831769454 doi: 10.1177/1010428317694544
4
Xiusheng Zhu, Lanyu Li, Bangjun Gao, Dandan Zhang, Yanyan Ren, Beibei Zheng, Mengmei Li, Deshun Shi, Ben Huang. Early development of porcine parthenogenetic embryos and reduced expression of primed pluripotent marker genes under the effect of lysophosphatidic acidReproduction in Domestic Animals 2018; 53(5): 1191 doi: 10.1111/rda.13226
5
Yan Liao, Ganggang Mu, Lingli Zhang, Wei Zhou, Jun Zhang, Honggang Yu. Lysophosphatidic Acid Stimulates Activation of Focal Adhesion Kinase and Paxillin and Promotes Cell Motility, via LPA1–3, in Human Pancreatic CancerDigestive Diseases and Sciences 2013; 58(12): 3524 doi: 10.1007/s10620-013-2878-4
6
Xiaoyun Tang, Matthew G.K. Benesch, David N. Brindley. Role of the autotaxin–lysophosphatidate axis in the development of resistance to cancer therapyBiochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids 2020; 1865(8): 158716 doi: 10.1016/j.bbalip.2020.158716
7
Yi Xiao, F. Peter Guengerich. Metabolomic analysis and identification of a role for the orphan human cytochrome P450 2W1 in selective oxidation of lysophospholipidsJournal of Lipid Research 2012; 53(8): 1610 doi: 10.1194/jlr.M027185
8
Nan Sethakorn, Nickolai O. Dulin. RGS expression in cancer: oncomining the cancer microarray dataJournal of Receptors and Signal Transduction 2013; 33(3): 166 doi: 10.3109/10799893.2013.773450
9
Fernanda Leve, Taline Guimarães Corrêa Marcondes, Lilian Gonçalves R. Bastos, Sarah Vieira Rabello, Marcelo Neves Tanaka, José Andrés Morgado-Díaz. Lysophosphatidic acid induces a migratory phenotype through a crosstalk between RhoA–Rock and Src–FAK signalling in colon cancer cellsEuropean Journal of Pharmacology 2011; 671(1-3): 7 doi: 10.1016/j.ejphar.2011.09.006
10
Gizem E. Genc, Victoria E.B. Hipolito, Roberto J. Botelho, Saadet Gumuslu. Lysophosphatidic acid represses autophagy in prostate carcinoma cellsBiochemistry and Cell Biology 2019; 97(4): 387 doi: 10.1139/bcb-2018-0164
11
Tamotsu Tsukahara, Kimiko Murakami-Murofushi. Release of Cyclic Phosphatidic Acid from Gelatin-based Hydrogels Inhibit Colon Cancer Cell Growth and MigrationScientific Reports 2012; 2(1) doi: 10.1038/srep00687
12
C. Chris Yun, Peijian He. Lysophospholipid Receptors2013; : 507 doi: 10.1002/9781118531426.ch24
13
Lianqing Lou, Yong Xin Chen, Lingzhen Jin, Xiaofei Li, Xingfei Tao, Jinhong Zhu, Xiangyi Chen, Shuang Wu, Weiwei Ye, Jinke He, Guoqiang Ding. Enhancement of invasion of hepatocellular carcinoma cells through lysophosphatidic acid receptorJournal of International Medical Research 2013; 41(1): 55 doi: 10.1177/0300060512474124
14
Jiyuan Sun. CARMA3: A novel scaffold protein in regulation of NF-κB activation and diseasesWorld Journal of Biological Chemistry 2010; 1(12): 353-361 doi: 10.4331/wjbc.v1.i12.353
15
Daphna Mokady, David Meiri. RhoGTPases – A novel link between cytoskeleton organization and cisplatin resistanceDrug Resistance Updates 2015; 19: 22 doi: 10.1016/j.drup.2015.01.001
16
Nasser Samadi, Raie Bekele, Dora Capatos, Ganesh Venkatraman, Meltem Sariahmetoglu, David N. Brindley. Regulation of lysophosphatidate signaling by autotaxin and lipid phosphate phosphatases with respect to tumor progression, angiogenesis, metastasis and chemo-resistanceBiochimie 2011; 93(1): 61 doi: 10.1016/j.biochi.2010.08.002
17
Silvia Anahi Valdés-Rives, Aliesha González-Arenas. Autotaxin-Lysophosphatidic Acid: From Inflammation to Cancer DevelopmentMediators of Inflammation 2017; 2017: 1 doi: 10.1155/2017/9173090
18
Ji-yuan Sun. GPCR-CARMA3-NF-kappaB signaling axis: A novel drug target for cancer therapyClinical Oncology and Cancer Research 2010; 7(3): 159 doi: 10.1007/s11805-010-0512-1
19
Derya Isler, Mehmet Ozaslan, Isik Didem Karagoz, Ibrahim Halil Kilic, Metin Karakok, Seyithan Taysi, Izzettin Guler, Ahmet Cakmak, Abdullah Tuncay Demiryurek. Antitumoral effect of a selective Rho-kinase inhibitor Y-27632 against Ehrlich ascites carcinoma in micePharmacological Reports 2014; 66(1): 114 doi: 10.1016/j.pharep.2013.06.006
20
A. Kuksis, Y. Itabashi, W. Pruzanski. Encyclopedia of Lipidomics2016; : 1 doi: 10.1007/978-94-007-7864-1_163-1
21
Anna Jesionowska, Elzbieta Cecerska-Heryc, Natalia Matoszka, Barbara Dolegowska. Lysophosphatidic acid signaling in ovarian cancerJournal of Receptors and Signal Transduction 2015; 35(6): 578 doi: 10.3109/10799893.2015.1026444